These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 35502494)
1. Cardiac hemangioma mimicking a neuroendocrine tumor on Shah A; Binkovitz L; Layman AJ; Bois MC; Nguyen B J Card Surg; 2022 Sep; 37(9):2849-2851. PubMed ID: 35502494 [TBL] [Abstract][Full Text] [Related]
2. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518 [TBL] [Abstract][Full Text] [Related]
3. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors. Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446 [TBL] [Abstract][Full Text] [Related]
5. The Detection of Cardiac Adrenocorticotropic Hormone-Secreting Neuroendocrine Tumor With the Help of 68Ga-DOTATATE PET/CT. Hou G; Jiang Y; Cheng X Clin Nucl Med; 2020 Feb; 45(2):136-138. PubMed ID: 31876827 [TBL] [Abstract][Full Text] [Related]
6. Unusual 68 Ga-DOTATATE Uptake in Primary Nodal Hemangioma of Axillary Lymph Node. Sariyildiz Gumusgoz H; Burak Z; Karasah Erkek B Clin Nucl Med; 2022 Sep; 47(9):809-810. PubMed ID: 35353744 [TBL] [Abstract][Full Text] [Related]
10. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243 [TBL] [Abstract][Full Text] [Related]
11. Combined Quantification of Lee H; Nakamoto R; Moore SE; Pantel AR; Eads JR; Aparici CM; Pryma DA Acad Radiol; 2022 Sep; 29(9):1308-1316. PubMed ID: 34836776 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor. Acar E; Kaya GÇ Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820 [TBL] [Abstract][Full Text] [Related]
13. Radioiodine Uptake in Incidentally Detected Neuroendocrine Tumor: Correlative Imaging With FDG PET/CT and 68 Ga-DOTATATE PET/CT. Hod N; Lantsberg S; Levin D Clin Nucl Med; 2022 Oct; 47(10):e643-e646. PubMed ID: 35485856 [TBL] [Abstract][Full Text] [Related]
14. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor. Chan M; Schembri GP Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429 [TBL] [Abstract][Full Text] [Related]
15. Clinical and Prognostic Value of PET/CT Imaging with Combination of Zhang P; Yu J; Li J; Shen L; Li N; Zhu H; Zhai S; Zhang Y; Yang Z; Lu M Contrast Media Mol Imaging; 2018; 2018():2340389. PubMed ID: 29681780 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor imaging with [ Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275 [TBL] [Abstract][Full Text] [Related]
17. Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT. Lu Y Clin Nucl Med; 2019 Nov; 44(11):914-915. PubMed ID: 31306189 [TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of Liu Q; Zang J; Yang Y; Ling Q; Wu H; Wang P; Lu L; Zhu Z Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4386-4395. PubMed ID: 34146130 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077 [TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor. Şahin R; Baykal Koca S; Yücetaş U; Çermik TF; Ergül N Clin Nucl Med; 2022 Jul; 47(7):e503-e505. PubMed ID: 35384913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]